(1-(6-Chloropyrimidin-4-yl)piperidin-3-yl)methanol

Catalog No.: 
ACVKPG361
CAS No.: 
939986-74-0
Molecular Formula: 
C10H14ClN3O
Molecular Weight: 
227.70
(1-(6-Chloropyrimidin-4-yl)piperidin-3-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$52.00In stockInquiry
250mg95%$78.00In stockInquiry
1g95%$155.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(6-Chloropyrimidin-4-yl)piperidin-3-yl)methanol
IUPAC Name(1-(6-chloropyrimidin-4-yl)piperidin-3-yl)methanol
MDL No.MFCD09607839
Molecular FormulaC10H14ClN3O
Molecular Weight227.70
SMILESOCC1CN(C2=NC=NC(Cl)=C2)CCC1
InChI KeyCLJDKIXEIMTDNB-UHFFFAOYSA-N
Synonym[1-(6-Chloro-pyriMidin-4-yl)-piperidin-3-yl]-Methanol, 98+% C10H14ClN3O, MW: 227.69;1-(6-Chloro-4-pyrimidinyl)-3-piperidinemethanol;3-Piperidinemethanol, 1-(6-chloro-4-pyrimidinyl)-;RMA-4174
CAS No.939986-74-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVKPG361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVKPG361 route product structure diagram
    ACVKPG361939986-74-0In Stock
Inquiry

2. ACVKPG361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVKPG361 route product structure diagram
    ACVKPG361939986-74-0In Stock
Inquiry

3. ACVKPG361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVKPG361 route product structure diagram
    ACVKPG361939986-74-0In Stock
Inquiry

Comments (0)